SEI Investments’s Day One Biopharmaceuticals DAWN Stock Holding History

SEI Investments’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.24M	Buy	104,598 +67,084	+179%	+$945K	﹤0.01%	1950
2025 Q4	$350K	Buy	+37,514	New	+$313K	﹤0.01%	2668
2023 Q2	–	Sell	-17,342	Closed	-$232K	–	2691
2023 Q1	$232K	Buy	+17,342	New	+$339K	﹤0.01%	2432

Other funds holding DAWN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

SEI Investments's DAWN Position: Q1 2026 in Review

SEI Investments increased its Day One Biopharmaceuticals (DAWN) stake by 179% in Q1 2026, buying an estimated $945K and bringing the position to 104,598 shares worth $2.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

SEI Investments first reported a position in DAWN in Q1 2023 and has held it in 3 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

SEI Investments held 104,598 shares of Day One Biopharmaceuticals worth $2.24M as of Q1 2026.
SEI Investments bought 67,084 Day One Biopharmaceuticals shares in Q1 2026, an estimated $945K.
Day One Biopharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #1950 holding.
SEI Investments first reported a position in Day One Biopharmaceuticals in Q1 2023 and has held it in 3 quarters since.
206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.